Concept information
Preferred term
Droxidopa
Type
-
mesh:Descriptor
Definition
- A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION.
Broader concept
Entry terms
- 13147-26-7 ((DL-Tyr)-isomer)
- 23651-95-8 (Droxidopa)
- 3,4-threo-DOPS
- DL-threo-3,4-Dihydroxyphenylserine
- J7A92W69L7
- L-Tyrosine, beta,3-dihydroxy-, threo-
- threo-DOPS
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
13147-26-7 ((DL-Tyr)-isomer)
-
23651-95-8 (Droxidopa)
-
J7A92W69L7
-
L-Threo-DOPS
-
L-Tyrosine, beta,3-dihydroxy-, threo-
URI
http://data.loterre.fr/ark:/67375/JVR-N71CM40R-S
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}